https://www.prnewswire.com/news-releases/heteros-nirmacom-is-worlds-first-generic-version-of-covid-19-oral-drug-paxlovid-to-receive-who-prequalification-301709991.html
Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive...
/PRNewswire/ -- Hetero, India's leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization...